1 treatment center
No centers match
Try a different search term
1 SAMHSA-listed treatment center in Conway, Arkansas. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.
Try a different search term
Free, confidential assistance matching you with the right program in Conway.
Conway, Arkansas has 1 SAMHSA-verified addiction treatment center offering 1 outpatient. Each facility listed here is verified through the Substance Abuse and Mental Health Services Administration (SAMHSA) and provides evidence-based treatment approaches.
Outpatient programs allow Conway residents to receive treatment while maintaining their daily responsibilities. Sessions are typically scheduled 3-5 days per week, making it possible to continue working or attending school.
Treatment centers in Conway accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
Residents of Conway accessing addiction treatment encounter a treatment system shaped by three federal frameworks: the Mental Health Parity and Addiction Equity Act (insurance parity), the ACA (substance-use disorder treatment as Essential Health Benefit), and 42 CFR Part 2 (heightened confidentiality of substance-use records). These protections apply universally — patients in Conway have the same legal foundations as patients anywhere in Arkansas or the broader U.S. The differences across providers are clinical (modalities, staffing, programming) and financial (insurance networks, self-pay terms).
Patients in Conway without insurance, or with insurance whose substance-use benefits fall short, have several alternatives: state-funded treatment slots (limited capacity, often with waitlists); Federally Qualified Health Centers providing outpatient addiction services on income-based sliding scales; faith-based residential programs that operate on charitable funding; and 12-step-based community recovery support that operates outside the formal treatment system. The SAMHSA National Helpline (1-800-662-HELP) can navigate uninsured patients to appropriate options in or near Conway.
Most Conway patients enter treatment at one of three levels: medically managed detox (if withdrawal risk warrants medical supervision), residential treatment (24-hour structured environment for those without stable recovery support at home), or intensive outpatient (9+ hours/week of programming for those able to maintain work/school and recover at home with structured support). The choice depends on ASAM criteria assessment performed by licensed clinicians, not solely on patient preference or insurance coverage limitations.
Employment re-entry after addiction treatment is a Conway priority that intersects with long-term recovery sustainability. The Americans with Disabilities Act protects employees in recovery from discrimination based on past substance use (current illegal use is not protected). FMLA may apply to treatment-related absences. State vocational rehabilitation services offer career counseling, education funding, and job placement support. Recovery-friendly employer initiatives are emerging in many U.S. markets including Arkansas.
Overdose response in Conway: signs of opioid overdose include slowed or stopped breathing, blue lips or fingertips, pinpoint pupils, unconsciousness, and limp body. If you suspect overdose, call 911 immediately, administer naloxone (Narcan nasal spray is most common), perform rescue breathing or CPR if trained, and stay with the person until paramedics arrive. Arkansas Good Samaritan laws generally protect callers from prosecution for drug-related offenses when seeking emergency help, with specific protections varying by state.
Same-day or rapid admission to Conway programs is most often possible at facilities with rolling intake capacity, particularly during weekday business hours. Weekend admissions are increasingly common but require advance arrangement. Emergency department presentation with active overdose or severe withdrawal sometimes serves as a bridge to Conway treatment entry — hospital case managers can coordinate transfer to residential treatment directly from ED, particularly for patients with insurance that covers acute stabilization plus subsequent residential.
Attention-deficit/hyperactivity disorder (ADHD) in Conway treatment patients raises specific clinical questions: ADHD medication continuation (stimulant medications can be appropriate even in addiction-recovery contexts but require careful prescribing), evaluation of whether substance use was self-medication for untreated ADHD, and behavioral interventions for executive-function deficits that complicate early-recovery tasks like appointment-keeping, financial management, and structured-day adherence. Adult ADHD remains under-diagnosed in addiction-treatment populations.